2011
DOI: 10.18553/jmcp.2011.17.9.695
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the Appropriateness of Serum Digoxin Concentration Measurement in a Medical Group Setting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
17
2

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 8 publications
1
17
2
Order By: Relevance
“…The fact that valve diseases and rhythm disorders are more common in women (14) and that mortality occurs at a later age compared to men may cause digoxin use to appear relatively higher in women. The 1.8-fold higher rate in older women observed in our study compared to older men supports this theory and is in accordance with the results of many studies in the literature (12,(14)(15)(16)(17)(18).…”
Section: Discussionsupporting
confidence: 93%
“…The fact that valve diseases and rhythm disorders are more common in women (14) and that mortality occurs at a later age compared to men may cause digoxin use to appear relatively higher in women. The 1.8-fold higher rate in older women observed in our study compared to older men supports this theory and is in accordance with the results of many studies in the literature (12,(14)(15)(16)(17)(18).…”
Section: Discussionsupporting
confidence: 93%
“…Rational use of therapeutic drug monitoring can help determine appropriate drug dosage and avoid toxic reactions. However, in previous studies the proportion of inappropriate monitoring ranged from 32 to 84% (Clague et al 1983;Copeland et al, 1992;Canas et al, 1999;Mordasini et al, 2002;Haim et al, 2002;Sidwell et al, 2003;Puche et al, 2004;Lippi et al, 2007;Orrico et al, 2011), suggesting that digoxin TDM is a tool that is difficult to use correctly. In these studies there was some variation in the criteria by which the quality of monitoring was assessed, making it difficult to directly compare findings.…”
Section: Discussionmentioning
confidence: 96%
“…Because of its narrow therapeutic index and large interindividual pharmacokinetic variability, it is important to know digoxin blood levels. However, studies have shown that procedures for digoxin serum concentration monitoring are frequently not within accepted guidelines (Clague et al, 1983;Copeland et al, 1992;Canas et al, 1999;Mordasini et al, 2002;Haim et al, 2002;Sidwell et al, 2003;Puche et al, 2004;Lippi et al, 2007;Orrico et al, 2011). Digoxin level monitoring performed without proper indication or with incorrect timing may not only significantly limit its benefits but also result in toxicity and unnecessary costs.…”
Section: Introductionmentioning
confidence: 99%
“…It has positive inotrope effects on heart muscles and the main indication of the drug is heart failure although it is not currently considered as the first line treatment (1). As therapeutic and toxic dosages of cardiac glycosides are almost identical, drug toxicity is common (2). Digoxin toxicity effects different parts of the body, such as the central nervous system with many side effects, such as headache, fatigue, dizziness and visual disturbances, digestive system such as nausea, vomiting, anorexia, and the cardiovascular system, such as arrhythmia (3)(4)(5).…”
Section: Introductionmentioning
confidence: 99%